Iterum Therapeutics (ITRM) Expected to Announce Quarterly Earnings on Friday

Iterum Therapeutics (NASDAQ:ITRM) is expected to announce its earnings results before the market opens on Friday, February 7th. Analysts expect the company to announce earnings of ($0.26) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Iterum Therapeutics Trading Up 1.3 %

NASDAQ:ITRM opened at $1.57 on Thursday. The firm has a fifty day simple moving average of $1.83 and a two-hundred day simple moving average of $1.43. Iterum Therapeutics has a 12 month low of $0.81 and a 12 month high of $3.02. The stock has a market capitalization of $43.21 million, a price-to-earnings ratio of -0.79 and a beta of 2.28.

About Iterum Therapeutics

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections.